Swissmedic approves Sobi ’s Alprolix to treat haemophilia B

The Swiss Agency for Therapeutic Products, Swissmedic, has approved Sobi ’s Alprolix (eftrenonacog alfa) for the treatment of haemophilia B.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news